In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Prognostic impact of left ventricle dysfunction in patients with pulmonary hypertension

Session Poster Session 3

Speaker Rafael Santos

Congress : Heart Failure 2019

  • Topic : valvular, myocardial, pericardial, pulmonary, congenital heart disease
  • Sub-topic : Pulmonary Hypertension
  • Session type : Poster Session
  • FP Number : P1820

Authors : R Santos (Lisbon,PT), R Placido (Lisbon,PT), T Guimaraes (Lisbon,PT), N Cortez-Dias (Lisbon,PT), JR Agostinho (Lisbon,PT), J Rigueira (Lisbon,PT), I Aguiar-Ricardo (Lisbon,PT), A Nunes-Ferreira (Lisbon,PT), T Rodrigues (Lisbon,PT), N Cunha (Lisbon,PT), NC Andre (Lisbon,PT), A Mineiro (Lisbon,PT), S Martins (Lisbon,PT), N Lousada (Lisbon,PT), FJ Pinto (Lisbon,PT)

R Santos1 , R Placido1 , T Guimaraes1 , N Cortez-Dias1 , JR Agostinho1 , J Rigueira1 , I Aguiar-Ricardo1 , A Nunes-Ferreira1 , T Rodrigues1 , N Cunha1 , NC Andre1 , A Mineiro2 , S Martins1 , N Lousada1 , FJ Pinto1 , 1Santa Maria University Hospital/CHULN, CAML, CCUL, Lisbon School of Medicine, Universidade de Lisboa, Cardiology Department - Lisbon - Portugal , 2Pulido Valente Hospital/CHULN, Pneumology Department - Lisbon - Portugal ,


Introduction: Left ventricular (LV) dysfunction is the main cause of pulmonary hypertension (PH) and is associated with a worse prognosis. However, the contributory factor of LV dysfunction in patients with predominantly pre-capillary PH is unclear.

Objective: to assess the prognostic impact of LV dysfunction in patients with PH.

Methods: Retrospective, single-center study of consecutive patients followed in the PH treatment center, with hemodynamic diagnosis of PH, submitted to transthoracic echocardiography at diagnosis.

The concomitant presence of LV dysfunction, classified as isolated diastolic dysfunction, systolic dysfunction or valvulopathy with hemodynamic repercussion was evaluated. The association of this variable with any cause mortality at 5 years was determined using the Kaplan Meier survival analysis and the Cox regression analysis.

Results: 176 patients were included, 69.9% female (N = 123), with a median age of 68 years (IQR: 24). LV dysfunction was identified in 28.4% (N = 49), with the majority (N = 40) presenting with group 2 PH.
The5-year mortality rate from any cause was27.3%.Patients with systolic dysfunction had 50%mortality at 5years, significantly higher than the other groups (p=0,001), being a predictor of mortality in this period (p=0,003).

Conclusion: The presence of left ventricular systolic dysfunction is associated with worse prognosis in PH patients.

Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are